During the past decade, Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava" #1 sponsor was "AEterna Zentaris" with 1 trials, followed by "Agennix" with 1 trials sponsored, "Biogen" with 1 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava" are "Cancer" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Complete Response" (1 trials), "Endometrial Cancer" (1 trials) and "Epithelial Ovarian Cancer" (1 trials). Many other conditions were trialed in "Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava" in a lesser frequency.

Most popular intervention types in "Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials), "Pemetrexed" (2 trials) and "AEZS-108 / zoptarelin doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Judetean de Urgenta "Sf. Ioan cel Nou" Suceava, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".